Helius is opposing decisions on how much of the costs of its PoNS device for MS can be reimbursed under U.S. public health ...

The National MS Society has awarded $4.6 million in funding for five research projects aiming to help restore lost function ...

Sanofi stopped a Phase 2 study of oditrasertib in relapsing and progressive MS after it failed to lower blood NfL levels ...

Adding Tecfidera to an immune tolerizing cell therapy could maximize therapeutic benefits for MS patients, according to a ...

Curiously, columnist Leigh Anne Nelson can't tolerate wearing socks. It's one of several foot symptoms of her MS.

A study involving identical twins suggests alterations in immune cells called CD8 T-cells may be early drivers of ...

SetPoint plans to launch a trial of its implant device, stimulating the vagus nerve to promote myelin repair, next year in ...

People with MS may have a slightly higher risk of developing cancer than the general population, per a 10-year population ...

Better adherence to an at-home therapy regimen with the PoNS device was linked to greater improvements in walking function in ...

As columnist Ben Hofmeister and his wife celebrate their 15th wedding anniversary, he reflects on how MS has shaped their marriage.

Faced with the loss of cognitive abilities from multiple sclerosis, columnist Ben Hofmeister grapples with a bout of depression.

Transplanting genetically engineered oligodendrocyte progenitor cells (OPCs), which give rise to mature myelin-making cells, significantly boosted myelin repair in mice with multiple sclerosis (MS ...